BINDING DOMAINS AGAINST CANCER-ASSOCIATED MUC1
The present disclosure relates to binding domains that bind cancer-associated MUC1, and binding moieties comprising such binding domains. The present disclosure further relates to the use of such binding domains or binding moieties in the treatment of cancer. The present disclosure also relates to nucleic acid encoding such binding domains or binding moieties, and a vector and cell comprising such nucleic acid..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 10. Aug. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
KLOOSTER RINSE [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-08-10, Last update posted on www.tib.eu: 2023-11-23, Last updated: 2023-12-01 |
|---|
| Patentnummer: |
US2023250190 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA017886309 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA017886309 | ||
| 003 | DE-627 | ||
| 005 | 20231201100117.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230829s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA017886309 | ||
| 035 | |a (EPA)US2023250190 | ||
| 035 | |a (EPA)81579809 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a KLOOSTER RINSE |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a BINDING DOMAINS AGAINST CANCER-ASSOCIATED MUC1 |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-08-10, Last update posted on www.tib.eu: 2023-11-23, Last updated: 2023-12-01 | ||
| 520 | |a The present disclosure relates to binding domains that bind cancer-associated MUC1, and binding moieties comprising such binding domains. The present disclosure further relates to the use of such binding domains or binding moieties in the treatment of cancer. The present disclosure also relates to nucleic acid encoding such binding domains or binding moieties, and a vector and cell comprising such nucleic acid. | ||
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000) | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a WIDJAJA IVY |4 aut | |
| 700 | 0 | |a MAYES PATRICK |4 aut | |
| 700 | 0 | |a NASTRI HORACIO G |4 aut | |
| 700 | 0 | |a ZHOU JING |4 aut | |
| 700 | 0 | |a GUPTA VIJAY |4 aut | |
| 700 | 0 | |a VARGHESE BINDU |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 10. Aug. |
| 773 | 1 | 8 | |g year:2023 |g day:10 |g month:08 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/81579809/publication/US2023250190A1?q=US2023250190 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2023 |b 10 |c 08 |
| 951 | |a AR | ||
| 952 | |j 2023 |b 10 |c 08 | ||